Gastric and Breast Cancer
SJR0.105
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.105 | Q4 | 1.1% | |
| 2024 | — | — | 0.109 | Q4 | 6.5% | |
| 2023 | — | — | 0.101 | Q4 | 8.5% | |
| 2022 | — | — | 0.101 | Q4 | 12.1% | |
| 2021 | — | — | 0.101 | Q4 | 14.5% | |
| 2020 | — | — | 0.101 | Q4 | 0.0% | |
| 2019 | — | — | 0.111 | Q4 | 13.2% | |
| 2018 | — | — | 0.102 | Q4 | 0.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
1109-7655
ISSN
1109-7647
region
Western Europe
coverage
2008-2012, 2017-2022